Meet the Top Presenters of Tech Tour Mental & Brain Health 2026

Clee Medical develops technologies for precision brain interventions. Its platform combines ultra-high-resolution intraoperative imaging, AI and minimally invasive access technologies, generating real-time insights and structured brain data to support neurosurgery and future neurotherapies.

Cumulus Neuroscience develops an AI-based digital biomarker platform designed to improve decision-making in clinical trials for central nervous system disorders. It combines tablet-based assessments with a dry-sensor brain-monitoring headset to measure brain function and behaviour over time.

Kara Connect provides an employer-sponsored wellbeing platform connecting employees with a network of more than 1,000 mental health and wellbeing practitioners across Europe. It also provides employers with real-time data on utilisation and return on investment.

NEUROBITE Technologies develops degradable implantable neural interfaces for brain healthcare. Its dissolvable neural probes provide temporary electrical stimulation and brain activity monitoring before resorbing, potentially reducing repeat neurosurgery and long-term implant risks, with initial applications in drug-resistant epilepsy.

Pheno Therapeutics develops GPR17 antagonists designed to promote remyelination in the central nervous system. Its lead candidate, PTD802, is Phase 1 ready, with an initial clinical focus on acute optic neuritis and subsequent applications in multiple sclerosis.

SOENIA® by BrainCare Oy develops remote long-term monitoring and therapeutic solutions for neurological conditions. Its technology focuses on subscalp EEG and a neurostimulation implant designed to continuously record seizure activity and provide closed-loop stimulation for refractory epilepsy.

Sonalis develops a non-invasive brain imaging and neural intervention platform using ultrasound. Its portable device combines high-resolution neuroimaging with targeted neuromodulation, with potential applications including epilepsy, depression and neurodegenerative diseases.

Don’t miss out on our upcoming events and the latest industry news. Explore upcoming Tech Tour events and sign up for our newsletter below.